.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Amitriptyline hydrochloride; perphenazine - Generic Drug Details

« Back to Dashboard
Amitriptyline hydrochloride; perphenazine is the generic ingredient in ten branded drugs marketed by Watson Labs, Schering, New River, Par Pharm, Ivax Sub Teva Pharms, Mylan, Sandoz, and Sun Pharm Inds, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for amitriptyline hydrochloride; perphenazine. Two suppliers are listed for this compound.

Summary for Generic Name: amitriptyline hydrochloride; perphenazine

Tradenames:10
Patents:0
Applicants:8
NDAs:37
Drug Master File Entries: see list13
Suppliers / Packaging: see list2
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: amitriptyline hydrochloride; perphenazine

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL071863-001Dec 21, 1987DISCNNo► subscribe► subscribe
Watson Labs
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070376-001Aug 25, 1986DISCNNo► subscribe► subscribe
Par Pharm
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
amitriptyline hydrochloride; perphenazine
TABLET;ORAL070595-001Sep 11, 1986DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: amitriptyline hydrochloride; perphenazine

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
New River
TRIAVIL 4-25
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-005Approved Prior to Jan 1, 19823,428,735► subscribe
New River
TRIAVIL 4-50
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014715-006Approved Prior to Jan 1, 19823,428,735► subscribe
Schering
ETRAFON-A
amitriptyline hydrochloride; perphenazine
TABLET;ORAL014713-002Approved Prior to Jan 1, 19823,428,735► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc